Sarmadi, M.; Gheibi, A.; Khanahmad, H.; Khorramizadeh, M.R.; Hejazi, S.H.; Zahedi, N.; Mianesaz, H.; Kashfi, K.
Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response. Vaccines 2022, 10, 388.
https://doi.org/10.3390/vaccines10030388
AMA Style
Sarmadi M, Gheibi A, Khanahmad H, Khorramizadeh MR, Hejazi SH, Zahedi N, Mianesaz H, Kashfi K.
Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response. Vaccines. 2022; 10(3):388.
https://doi.org/10.3390/vaccines10030388
Chicago/Turabian Style
Sarmadi, Mahdieh, Azam Gheibi, Hossein Khanahmad, Mohammad Reza Khorramizadeh, Seyed Hossein Hejazi, Noushin Zahedi, Hamidreza Mianesaz, and Khosrow Kashfi.
2022. "Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response" Vaccines 10, no. 3: 388.
https://doi.org/10.3390/vaccines10030388
APA Style
Sarmadi, M., Gheibi, A., Khanahmad, H., Khorramizadeh, M. R., Hejazi, S. H., Zahedi, N., Mianesaz, H., & Kashfi, K.
(2022). Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response. Vaccines, 10(3), 388.
https://doi.org/10.3390/vaccines10030388